Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,918 | 36 | 58.9% |
| Food and Beverage | $14,069 | 674 | 28.6% |
| Honoraria | $4,975 | 3 | 10.1% |
| Travel and Lodging | $1,066 | 8 | 2.2% |
| Consulting Fee | $71.00 | 1 | 0.1% |
| Education | $39.06 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $9,353 | 114 | $0 (2024) |
| Allergan, Inc. | $7,278 | 78 | $0 (2022) |
| Depomed, Inc. | $7,071 | 24 | $0 (2017) |
| PFIZER INC. | $6,168 | 66 | $0 (2024) |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | $5,574 | 25 | $0 (2020) |
| Purdue Pharma L.P. | $5,044 | 18 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $1,272 | 69 | $0 (2024) |
| Nevro Corp. | $814.49 | 14 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $540.00 | 14 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $482.57 | 32 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $835.00 | 42 | ABBVIE INC. ($314.53) |
| 2023 | $1,312 | 61 | AbbVie Inc. ($762.60) |
| 2022 | $3,540 | 70 | ABBVIE INC. ($2,482) |
| 2021 | $7,979 | 96 | AbbVie Inc. ($5,794) |
| 2020 | $6,749 | 84 | Allergan, Inc. ($5,774) |
| 2019 | $1,807 | 92 | Scilex Pharmaceuticals Inc. ($189.85) |
| 2018 | $6,115 | 125 | BioDelivery Sciences International, Inc. ($2,834) |
| 2017 | $20,801 | 155 | Depomed, Inc. ($7,071) |
All Payment Transactions
725 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: PAIN | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: PAIN | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: Opioid Analgesic | ||||||
| 10/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.55 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: PAIN | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.10 | General |
| Category: NEUROLOGY | ||||||
| 09/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.88 | General |
| Category: NEUROLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: PAIN | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: PAIN | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: PAIN | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: PAIN | ||||||
| 06/12/2024 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: Opioid Analgesic | ||||||
| 05/30/2024 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Opioid Analgesic | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 622 | 10,532 | $340,657 | $159,975 |
| 2022 | 9 | 496 | 12,761 | $462,931 | $145,965 |
| 2021 | 8 | 461 | 13,157 | $239,602 | $153,954 |
| 2020 | 12 | 612 | 15,201 | $261,698 | $158,251 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 398 | $72,600 | $45,599 | 62.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 18 | 9,201 | $64,050 | $44,987 | 70.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 434 | $78,597 | $33,279 | 42.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 68 | 137 | $49,382 | $12,507 | 25.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 60 | 68 | $41,289 | $11,041 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $15,730 | $8,058 | 51.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 22 | 40 | $7,250 | $1,918 | 26.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 84 | 126 | $2,520 | $1,556 | 61.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 53 | $8,478 | $914.40 | 10.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 20 | $760.00 | $116.85 | 15.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 20 | 11,707 | $81,949 | $57,351 | 70.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 148 | 569 | $134,621 | $42,758 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 211 | $71,145 | $21,694 | 30.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 37 | 38 | $48,553 | $6,363 | 13.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 42 | 59 | $77,488 | $5,894 | 7.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 57 | 97 | $15,520 | $4,184 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $13,222 | $3,923 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $9,234 | $2,523 | 27.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 18 | 28 | $11,200 | $1,274 | 11.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 23 | 11,903 | $83,321 | $56,126 | 67.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 157 | 815 | $86,082 | $54,109 | 62.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 283 | $45,186 | $29,217 | 64.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $12,133 | $7,698 | 63.4% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 17 | 30 | $6,287 | $4,064 | 64.6% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 27 | 36 | $3,083 | $1,874 | 60.8% |
About Bradley Cash, MD,PMR
Bradley Cash, MD,PMR is a Physical Medicine & Rehabilitation healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568423358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bradley Cash, MD,PMR has received a total of $49,138 in payments from pharmaceutical and medical device companies, with $835.00 received in 2024. These payments were reported across 725 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,918).
As a Medicare-enrolled provider, Cash has provided services to 2,191 Medicare beneficiaries, totaling 51,651 services with total Medicare billing of $618,146. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location White Plains, NY
- Active Since 03/31/2006
- Last Updated 01/23/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1568423358
Products in Payments
- UBRELVY (Drug) $14,109
- Nucynta (Drug) $7,207
- BELBUCA (Drug) $5,293
- HYSINGLA ER (Drug) $4,891
- LYRICA (Drug) $3,030
- EMBEDA (Drug) $2,688
- BOTOX (Biological) $1,451
- XTAMPZA (Drug) $885.53
- QULIPTA (Drug) $829.67
- Omnia (Device) $549.83
- SYNVISC-ONE (Device) $540.00
- Horizant (Drug) $526.83
- NURTEC ODT (Drug) $494.32
- RELISTOR ORAL (Drug) $399.27
- iFuse Implant (Device) $293.91
- Aimovig (Biological) $267.24
- BUNAVAIL 2.1 mg 30-count box (Drug) $261.12
- ZTLido (Drug) $249.53
- EMGALITY (Drug) $234.72
- RESTORE (Device) $231.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in White Plains
Dr. Lyle Posecion, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $9,500
Lata Bhansali, M. D, M. D
Physical Medicine & Rehabilitation — Payments: $485.55
Dr. Andrew Abdou, Do, DO
Physical Medicine & Rehabilitation — Payments: $456.15
Moo-Yeon Oh-Park, Md, MD
Physical Medicine & Rehabilitation — Payments: $421.97
Dr. Stephen Andrus, Md, MD
Physical Medicine & Rehabilitation — Payments: $288.67
Dr. Eric Roberts, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $275.84